Research and Markets (http://www.researchandmarkets.com/research/pbg3zv/squamous) has announced the addition of the "Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2016" report to their offering.

Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Squamous Non-Small Cell Lung Cancer. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Squamous Non-Small Cell Lung Cancer.

The report also assesses the Squamous Non-Small Cell Lung Cancer therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

  • The report provides competitive pipeline landscape of Squamous Non-Small Cell Lung Cancer
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Squamous Non-Small Cell Lung Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Squamous Non-Small Cell Lung Cancer and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Squamous Non-Small Cell Lung Cancer Overview
  2. Squamous Non-Small Cell Lung Cancer Pipeline Therapeutics
  3. Squamous Non-Small Cell Lung Cancer Therapeutics under Development by Companies
  4. Squamous Non-Small Cell Lung Cancer Filed and Phase III Products
  5. Comparative Analysis
  6. Squamous Non-Small Cell Lung Cancer Phase II Products
  7. Squamous Non-Small Cell Lung Cancer Phase I and IND Filed Products
  8. Squamous Non-Small Cell Lung Cancer Discovery and Pre-Clinical Stage Products
  9. Squamous Non-Small Cell Lung Cancer - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Squamous Non-Small Cell Lung Cancer - Discontinued Products
  15. Squamous Non-Small Cell Lung Cancer - Dormant Products
  16. Companies Involved in Therapeutics Development for Squamous Non-Small Cell Lung Cancer

For more information visit http://www.researchandmarkets.com/research/pbg3zv/squamous